Amit Patel - Quotient Sciences

Amit Patel

Senior Director of Technical Services

About

Amit Patel, Senior Director of Technical Services, has held various technical and operational leadership roles during his 15-year career in the pharmaceutical industry. 

Amit has led projects from conceptualization to commercialization for solid oral dosage forms of complex modified release and immediate release formulations. During his career, he has also gained extensive regulatory and quality systems experience, including support for regulatory audits, and expertise in process optimization through concepts of Quality by Design (QbD), process validation, cleaning validation, and product life cycle management.

Since joining Quotient Sciences, Amit has been overseeing process development, registration, process validation, and continued process verification of our late-stage and commercial drug product manufacturing programs. Prior to Quotient Sciences, Amit worked with Nesher Pharmaceuticals, where he led the formulation development and technical services departments. 

Amit holds a Master of Pharmaceutical Chemistry from Fairleigh Dickinson University and a Bachelor of Pharmacy from Sardar Patel University Gujarat.

Quotient Sciences Logo
Commercial Manufacturing, Pediatrics, Oncology

Quotient Sciences' Commercial Manufacturing Capabilities

Read More

Latest news from Quotient Sciences

More News
News & Announcements, Articles & Publications, commercial manufacturing, Dr. Helen Baker, Dr. Richard Castledine Dr. Helen Baker and Dr. Richard Castledine contribute to Pharmaceutical Technology's 'Poor API Quality Threatens a Healthy Supply' By: Dr. Helen Baker and Dr. Richard Castledine
Read More
News & Announcements, Articles & Publications, Thierry Van Nieuwenhove Thierry Van Nieuwenhove on the Future of CDMO Partnerships By: Thierry Van Nieuwenhove
Read More
News & Announcements, Translational Pharmaceutics®, Articles & Publications BioPharm International interviews Helen Baker about how Quotient Sciences is optimizing drug development
Read More
Get in touch
Humanity can't afford to wait, so neither can we.